Subtitle
Proton beam therapy is a safe and feasible treatment for patients with second primary lung cancer after lung resection.
Subtitle
Proton beam therapy is a safe and feasible treatment for patients with second primary lung cancer after lung resection.
Proto therapy Time
December 2018
Executive summary
A study from Japan reported 19 patients who were diagnosed with second primary lung cancer after lung resection, underwent PBT. This study reported the three-year overall survival rate was 63.2% and the three-year local control rate was 84.2%.
No grade 4 or 5 toxicities were observed after PBT. The authors concluded that PBT is a safe and feasible treatment for second primary lung cancer compared to surgery or X-ray radiotherapy. PBT may become a treatment choice for patients with second primary lung cancer after lung resection.
Top cancer treatments
Related contents
Proton Therapy Publication
June 2024
Proton and carbon ion radiotherapy for operable early-stage lung cancer; a prospective nationwide registry.
Proton Therapy Publication
July 2024
A Pilot Trial of Proton Based Cardiac Sparing Accelerated Fractionated RadioTherapy in Unresectable Non-Small Cell Lung Cancer with Extended Durvalumab Therapy (PARTICLE-D).
Proton Therapy Publication
August 2024
Sparing of the heart facilitates recovery from cardiopulmonary side effects after thoracic irradiation.
Proton Therapy Publication
August 2024
Parallel explorations in LA-NSCLC: Chemoradiation dose-response optimisation considering immunotherapy and cardiac toxicity sparing.
Proton Therapy Publication
April 2024
A bibliometric analysis of cardiotoxicity in cancer radiotherapy.
Proton Therapy Publication
March 2024
FLASH radiotherapy for the treatment of symptomatic bone metastases in the thorax (FAST-02): protocol for a prospective study of a novel radiotherapy approach.
Proton Therapy Publication
February 2024
Prospective study investigating hypofractionated proton beam therapy in patients with inoperable early stage non-small cell lung cancer.
Proton Therapy Publication
April 2024
Long-term survival outcomes and quality of life of image-guided proton therapy for operable stage I non-small cell lung cancer: A phase 2 study.
Proton Therapy Publication
January 2024
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy.